Search

Your search keyword '"Drug approval -- Technology application"' showing total 124 results
Start Over Descriptor "Drug approval -- Technology application" Topic business
124 results on '"Drug approval -- Technology application"'

1. Odine Participates in TAoeBA[degree sign]TAK-Approved R&D Project

Subjects
High technology industry -- Technology application, Drug approval -- Technology application, Machine learning -- Technology application, Technology application, Business, Computers and office automation industries, Telecommunications industry
Abstract

INTERNET BUSINESS NEWS-(C)1995-2024 M2 COMMUNICATIONS Istanbul-based Odine, a global technology partner specializing in sustainable network transformation, is participating in a new TÜBITAK-approved R&D project, supported by the European Commission's Eureka [...]

Published
2024

2. Odine Participates in TAoeBA[degree sign]TAK-Approved R&D Project

Subjects
High technology industry -- Technology application, Drug approval -- Technology application, Machine learning -- Technology application, Technology application, Business
Abstract

M2 EQUITYBITES-October 22, 2024-Odine Participates in TÃoeBÄ[degree sign]TAK-Approved R&D Project (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Istanbul-based Odine, a global technology partner specializing in sustainable network transformation, is participating in a new [...]

Published
2024

3. Odine Participates in TAoeBA[degree sign]TAK-Approved R&D Project

Subjects
High technology industry -- Technology application, Drug approval -- Technology application, Machine learning -- Technology application, Technology application, Business, Telecommunications industry
Abstract

TELECOMWORLDWIRE-October 22, 2024-Odine Participates in TÃoeBÄ[degree sign]TAK-Approved R&D Project (C)1994-2024 M2 COMMUNICATIONS http://www.m2.co.uk Istanbul-based Odine, a global technology partner specializing in sustainable network transformation, is participating in a new TÜBITAK-approved [...]

Published
2024

4. German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications

Subjects
High technology industry -- Technology application, Automobile industry -- Market research, Drug approval -- Technology application, Sleep -- Technology application, Marketing research, Technology application, Automobile Industry, Business, News, opinion and commentary
Abstract

Monitoring biosignals for both drivers and passengers - Analyzing and diagnosing with FDA-approved algorithm SEOUL, South Korea, May 6, 2024 /PRNewswire/ -- Amid the rapid advancement in automobile healthcare and [...]

Published
2024

5. Lumicell Announces FDA Advisory Committee's Positive Recommendation on the Benefit-Risk Profile of LUMISIGHT[TM] in the Detection of Cancerous Tissue During Breast Conserving Surgery

Subjects
United States. Food and Drug Administration -- Technology application, Cancer -- Diagnosis, Lumpectomy -- Technology application, Drug approval -- Technology application, Medical imaging equipment -- Technology application, Technology application, Business, Business, international
Abstract

NEWTON, Mass. -- Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer, today announced the Medical Imaging Drugs Advisory Committee (MIDAC) of the U.S Food [...]

Published
2024

6. ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors

Subjects
Tumors -- Drug therapy, Biological products -- Technology application, Drug approval -- Technology application, Monoclonal antibodies -- Technology application, Technology application, Banking, finance and accounting industries, Business, Trodelvy (Medication)
Abstract

SAN FRANCISCO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc., a biotech company with a unique technology for tunable half-life extension of drugs, announced publication of a paper entitled 'Could [...]

Published
2024

7. Halozyme Announces Takeda Receives FDA Approval for HYQVIA Co-formulated with ENHANZE as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Subjects
United States. Food and Drug Administration -- Technology application, Polyneuropathies -- Drug therapy, Drugs -- Vehicles, Drug approval -- Technology application, Adults -- Technology application, Drug delivery systems -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

SAN DIEGO, Jan. 16, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ('Halozyme') today announced that Takeda received U.S. Food and Drug Administration (FDA) approval for HYQVIA[Immune Globulin Infusion 10% [...]

Published
2024

8. Concerto Biosciences' Ensemble No.2 (ENS-002) IND application receives US FDA approval

Subjects
United States. Food and Drug Administration -- Technology application, Atopic dermatitis -- Technology application, Biotechnology industry -- Technology application, Drug approval -- Technology application, Technology application, Business
Abstract

M2 EQUITYBITES-June 27, 2024-Concerto Biosciences' Ensemble No.2 (ENS-002) IND application receives US FDA approval (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Concerto Biosciences, a US-based biotechnology company, announced on Wednesday that it has [...]

Published
2024

9. Gamida Cell says FDA accepts biologics license application for for omidubicel

Subjects
United States. Food and Drug Administration -- Technology application, Drugs -- Prescribing, Hematopoietic stem cells -- Transplantation -- Technology application, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

Gamida Cell announced that the U.S. Food and Drug Administration has accepted for filing the Company's Biologics License Application for omidubicel for the treatment of patients with blood cancers in [...]

Published
2022

10. RetinalGeniX(TM) Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

Subjects
Macular degeneration -- Technology application, Drugs -- Technology application -- Intellectual property, Drug approval -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX(TM) Technologies Inc. (OTCQB:RTGN) ('RetinalGeniX' or the 'Company'), today announced that it has submitted two provisional patent applications to the US Patent [...]

Published
2023

11. Good news: The 'Second Scorching Heat List' list was released, and Bangyao Biotechnology won the title of 'Scorching Star Enterprise'!

Subjects
Biotechnology -- Technology application, Drug approval -- Technology application, Technology application, Business, Business, international
Abstract

Shanghai Bangyao Biotechnology was honored with the 'Star Enterprise' title in the 'Second Ignite Heat List' by CIC Ignition Consulting. The company, known for its gene editing technology, has multiple [...]

Published
2024

12. CARBIOS Active approved by FDA for food contact applications

Subjects
United States. Food and Drug Administration -- Technology application, Drug approval -- Technology application, Biopolymers -- Technology application, Technology application, Business
Abstract

M2 EQUITYBITES-March 5, 2024-CARBIOS Active approved by FDA for food contact applications (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk CARBIOS (Euronext Growth Paris:ALCRB), a developer of biological technologies for processing end-of-life of plastics [...]

Published
2024

13. Levena Biopharma announces clinical data for A166 in breast cancer

Subjects
Biological products industry -- Technology application, Biological products -- Technology application, Drug approval -- Technology application, Breast cancer -- Care and treatment, Technology application, Business, News, opinion and commentary, Kadcyla (Medication)
Abstract

Sorrento Therapeutics announced that its license and development partner, Sichuan Kelun-Biotech Biopharmaceutical, presented at this year's Chinese Society of Clinical Oncology Guideline Conference Phase 1 data for its anti-HER2-ADC, A166. [...]

Published
2022

14. Scottsdale's Aesthetic IQ Clinic Offers Breakthrough Undereye Treatment, Restylane Eyelight

Subjects
United States. Food and Drug Administration -- Technology application, Hyaluronic acid -- Technology application, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary, Restylane (Medication)
Abstract

The newest hyaluronic acid filler by Galderma is now FDA-approved SCOTTSDALE, Ariz., Sept. 13, 2023 /PRNewswire-PRWeb/ -- Aesthetic IQ Clinic now offers Galderma's newest hyaluronic acid filler that was recently [...]

Published
2023

15. CSPC Pharmaceutical Group's GLP-1 target drug project is approved as a major scientific and technological innovation project

Subjects
Drug approval -- Technology application, Type 2 diabetes -- Technology application, Glucagon -- Technology application, Technology application, Business, Business, international
Abstract

CSPC Pharmaceutical Group. Recently, the Shandong Provincial Department of Science and Technology issued the 'Notice on the Release of Shandong Province Key Research and Development Plan (Major Scientific and Technological [...]

Published
2023

16. SimonMed Imaging Implements 3rd Generation iCAD Breast AI 3.0

Subjects
Cancer -- Diagnosis, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

At no additional cost to patients SCOTTSDALE, Ariz., June 29, 2023 /PRNewswire/ -- SimonMed Imaging, one of the largest outpatient imaging providers in the US, announced today it has completed [...]

Published
2023

17. GALDERMA RECEIVES FDA APPROVAL FOR ITS NEWEST HYALURONIC ACID FILLER, RESTYLANE EYELIGHT

Subjects
United States. Food and Drug Administration -- Technology application, Hyaluronic acid -- Technology application, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary, Restylane (Medication)
Abstract

Restylane Eyelight is the first and only product in the U.S. to use NASHA Technology to improve the appearance of undereye hollows for up to 18 months[sup.1] DALLAS, June 5, [...]

Published
2023

18. Xenex Makes De Novo Petition to FDA for LightStrike UV Room Disinfection Technology

Subjects
United States. Food and Drug Administration -- Technology application, Infection control -- Technology application, Medical equipment -- Technology application, Methicillin -- Technology application, Drug approval -- Technology application, Physiological apparatus -- Technology application, Technology application, Business, Business, international
Abstract

Robots Destroy Germs in Healthcare Facilities SAN ANTONIO -- Xenex Disinfection Services, the world leader in UV disinfection technology for healthcare facilities, today announced it has filed a De Novo [...]

Published
2023

19. AbbVie submits regulatory applications for SKYRIZI to FDA, EMA

Subjects
United States. Food and Drug Administration -- Technology application, Psoriasis -- Drug therapy, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

AbbVie announced that it has submitted applications seeking approval for SKYRIZI to the U.S. FDA and for SKYRIZI to the European Medicines Agency for the treatment of adults with active [...]

Published
2021

20. AbbVie submits regulatory applications to FDA, EMA for RINVOQ

Subjects
United States. Food and Drug Administration -- Technology application, Atopic dermatitis -- Care and treatment, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary, Rinvoq (Medication)
Abstract

AbbVie announced that it has submitted applications to the U.S. Food and Drug Administration and European Medicines Agency seeking approval for RINVOQ for the treatment of adults and adolescents with [...]

Published
2020

21. Lantheus receives FDA approval for Vialmix RFID for Definity sNDA

Subjects
Drug approval -- Technology application, RFID equipment -- Technology application, Technology application, Radio frequency identification, Business, News, opinion and commentary
Abstract

Lantheus announced the FDA has approved the supplemental new drug application, or sNDA, for Vialmix RFID for Definity. Vialmix RFID is a next generation activation device designed specifically for Definity [...]

Published
2020

22. Ironwood and Allergan get notice of allowance for LINZESS patent applications

Subjects
Irritable bowel syndrome -- Technology application, Drug approval -- Technology application, Linaclotide -- Technology application, Suffering, Marketing, Trademarks, Constipation, Women, Technology application, Business, News, opinion and commentary, Linzess (Medication) -- Intellectual property
Abstract

Ironwood (IRWD) announced that the United States Patent and Trademark Office has issued Notices of Allowance for patent applications covering the formulation of the 72 mcg dose of LINZESS, or [...]

Published
2020

23. Janssen submits FDA applications for two juvenile indications for Simponi Aria

Subjects
United States. Food and Drug Administration -- Technology application, Johnson & Johnson -- Technology application, Tumor necrosis factor -- Technology application, Pharmaceutical industry -- Technology application, Drug approval -- Technology application, Arthritis -- Technology application, Antiarthritic agents -- Technology application, Psoriatic arthritis, Necrosis, Methotrexate, Tumors, Psoriasis, Technology application, Business, News, opinion and commentary, Simponi (Medication)
Abstract

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of two supplemental Biologics License Applications, or sBLAs, to the U.S. Food and Drug Administration seeking approval of Simponi [...]

Published
2020

24. Aphaia Pharma Announces Enrollment of First Patient in Phase 2 Study of APH-012 for Chronic Weight Management in Individuals with Obesity

Subjects
United States. Food and Drug Administration -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Obesity -- Care and treatment, Drugs -- Vehicles, Drug approval -- Technology application, Drug delivery systems -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

ZUG, Switzerland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Aphaia Pharma, a clinical-stage biopharmaceutical company harnessing precision-targeted drug delivery technology for the treatment and prevention of metabolic diseases, today announced that [...]

Published
2022

25. First Patient Enrolled in Stage 2 of Pivotal Study of SetPoint Medical's Pioneering Technology for the Treatment of Rheumatoid Arthritis

Subjects
Rheumatoid factor -- Technology application, Antirheumatic agents -- Technology application, Arthritis -- Drug therapy, Drug approval -- Technology application, Technology application, Business, Business, international
Abstract

Results From RESET-RA Study Will Support FDA Submission for Approval of This Promising Treatment Approach for RA VALENCIA, Calif. -- SetPoint Medical, a clinical-stage healthcare company dedicated to patients with [...]

Published
2022

26. PerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection

Subjects
United States. Food and Drug Administration -- Technology application, Automation -- Technology application, Diagnostic reagents -- Technology application, T cells -- Technology application, Tuberculosis -- Technology application, Drug approval -- Technology application, Mechanization -- Technology application, Technology application, Workflow software, Business, Business, international
Abstract

T-Cell Select reagent kit simplifies the T-SPOT.TB test laboratory workflow through automation expanding access to the most sensitive latent TB test on the market WALTHAM, Mass. -- PerkinElmer's (NYSE: PKI) [...]

Published
2022

27. Esaote North America installs the first Magnifico(TM) Open MRI system in Tennessee

Subjects
Magnetic resonance imaging -- Technology application, Drug approval -- Technology application, Medical imaging equipment -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

FISHERS, Ind., July 11, 2022 /PRNewswire/ -- Coming off the heels of FDA approval, Esaote North America, Inc. is excited to announce the first installation of the Magnifico(TM) Open MRI [...]

Published
2022

28. Strathroy Middlesex General Hospital becomes the first hospital in southwest Ontario region to adopt MOLLI for breast cancer localization

Subjects
Drug approval -- Technology application, Breast cancer -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

The Strathroy Middlesex General Hospital (SMGH) has adopted MOLLI - a precise, easy-to-use new technology for breast cancer localization. STRATHROY, Ontario, July 7, 2022 /PRNewswire-PRWeb/ -- The Strathroy Middlesex General [...]

Published
2022

29. Toledo Plan Commission approves special use permits

Subjects
City councils -- Technology application, Service stations (Motor vehicles) -- Technology application, Drug approval -- Technology application, Convenience stores -- Licensing, certification and accreditation, Technology application, Business, General interest, Business, regional
Abstract

Byline: Kate Snyder Oct. 15The Toledo City Plan Commission approved a number of requests during its Thursday meeting, including applications for a drug and alcohol treatment facility on West Sylvania [...]

Published
2021

30. Pfizer says FDA grants XTANDI application priority review

Subjects
United States. Food and Drug Administration -- Technology application, Pfizer Inc. -- Technology application, Prostate cancer -- Care and treatment -- Technology application, Pharmaceutical industry -- Technology application, Drug approval -- Technology application, Grants-in-aid -- Technology application, Hormones, Cancer metastasis, Technology application, Business, News, opinion and commentary, Xtandi (Medication)
Abstract

Astellas Pharma and Pfizer announced that the U.S. Food and Drug Administration has accepted for review the filing of a supplemental New Drug Application for XTANDI to add an indication [...]

Published
2019

31. Judge orders FDA to set 10-month deadline for e-cig applications, Reuters says

Subjects
Cigarettes -- Technology application, Tobacco industry -- Technology application, Drug approval -- Technology application, Antismoking movement, Electronic cigarettes, Independent regulatory commissions, Technology application, Business, News, opinion and commentary
Abstract

U.S. Judge Paul Grimm has ordered the FDA to impose a 10-month deadline for the submission of e-cigarette applications, Reuters reports. Last month, the FDA proposed a shorter timeline after [...]

Published
2019

32. Moleculin Biotech files new Annamycin patents after FRA Fast Track approval

Subjects
Clinical trials -- Technology application, Biotechnology -- Technology application, Patents -- Technology application, Drug approval -- Technology application, Recurrence (Disease), Acute myelocytic leukemia, Myeloid leukemia, Orphan drugs, Patent/copyright issue, Technology application, Business, News, opinion and commentary
Abstract

Moleculin Biotech has filed new patents covering the production and reconstitution of Annamycin, which is currently in two clinical trials for the treatment of relapsed or refractory acute myeloid leukemia. [...]

Published
2019

33. SetPoint: First Patient Enrolled in Stage 2 of Pivotal Study of Medical's Pioneering Technology for the Treatment of Rheumatoid Arthritis

Subjects
Rheumatoid factor -- Technology application, Antirheumatic agents -- Technology application, Arthritis -- Drug therapy, Drug approval -- Technology application, Technology application, Business, Business, international, Telecommunications industry
Abstract

SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, reported the enrollment of the first participant in Stage 2 of the company's RESET-RA pivotal study. The [...]

Published
2022

34. Verismo Therapeutics submits SynKIR-110 IND application to US FDA

Subjects
United States. Food and Drug Administration -- Technology application -- Planning, T cells -- Technology application, Clinical trials -- Technology application, Drug approval -- Technology application, Ovarian cancer -- Technology application, Company business planning, Technology application, Business
Abstract

M2 EQUITYBITES-August 22, 2022-Verismo Therapeutics submits SynKIR-110 IND application to US FDA (C)2022 M2 COMMUNICATIONS http://www.m2.com Verismo Therapeutics, a US-based company behind the novel KIR-CAR platform technology for CAR T-cell [...]

Published
2022

35. DiRx Partners with Glassbox to Advance Digital Healthcare Solutions

Subjects
Mobile applications -- Technology application, Consumer behavior -- Technology application, Pharmacy -- Technology application, Drug approval -- Technology application, Web services -- Technology application, Technology application, Web services, Business, Business, international
Abstract

DiRx adopts Glassbox's solutions to enable frictionless pharmacy-to-patient digital journeys NEW YORK -- Glassbox, the leading provider of digital experience analytics for web and mobile applications, today announced that DiRx, [...]

Published
2021

36. TriLink BioTechnologies(R) Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea

Subjects
Food -- Safety and security measures, Biotechnology -- Technology application, RNA -- Technology application, Drug approval -- Technology application, Vaccines -- Product development, Technology application, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Oct 04, 2021 (GLOBE NEWSWIRE via COMTEX) -- TriLink BioTechnologies ('TriLink'), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, [...]

Published
2021

37. Harbour BioMed Announces NMPA Approval of Two IND Applications for Next-Generation Anti-CTLA-4 Antibody HBM4003

Subjects
Viral antibodies -- Technology application, Clinical trials -- Technology application, Drug approval -- Technology application, Antibodies -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 14, 2021 /PRNewswire/ -- Harbour BioMed ('HBM', HKEX: 02142) announced that the China National Medical Products Administration (NMPA) has approved its [...]

Published
2021

38. GigaGen Publishes Research on Company's Recombinant Hyperimmunes in Nature Biotechnology

Subjects
Grifols S.A. -- Technology application, Biological products -- Technology application, Biotechnology -- Technology application, Biotechnology industry -- Technology application, Viral antibodies -- Technology application, Drug approval -- Technology application, Antibodies -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

SOUTH SAN FRANCISCO, Apr 15, 2021 (GLOBE NEWSWIRE via COMTEX) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and [...]

Published
2021

39. The future of pharmacovigilance and the impact of automation

Author

Balderson, David J.

Subjects
Drug approval -- Technology application, Clinical trials, Technology application, Business, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Business, international
Abstract

Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent years. Although PV starts during [...]

Published
2019

40. New Robots for Medical & Pharmaceutical Applications

Subjects
Robotics industry -- Technology application, Robots -- Technology application, Drug approval -- Technology application, Clean rooms -- Technology application, Robotics industry, Technology application, Robot, Business, Chemicals, plastics and rubber industries
Abstract

Sepro Group says its new MED Series of three-, five- and six-axis robots will meet growing demand for automation in clean rooms and other sensitive environments in medical and pharmaceutical [...]

Published
2021

41. Blue Prism and ibi to Fast Track Covid-19 Vaccine Management

Subjects
Information Builders Inc. -- Technology application -- Management, Vaccination -- Technology application, Computer software industry -- Technology application, Health care industry -- Technology application, Drug approval -- Technology application, Vaccines -- Technology application, Health care industry, Company business management, Technology application, Business, News, opinion and commentary
Abstract

Intelligent Automation Contributes to the Efficient Management of Vaccination Operations LONDON and AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ -- Blue Prism (AIM: PRSM) and Information Builders, Inc. (ibi) are partnering [...]

Published
2021

42. Halozyme Announces Janssen Submission Of Applications In US And EU Seeking Approval Of DARZALEX FASPRO(TM)/ DARZALEX Subcutaneous (SC) Formulation Utilizing ENHANZE Technology, Combination With Pomalidomide And Dexamethasone For Patients With Relapsed Or Refractory Multiple Myeloma

Subjects
United States. Food and Drug Administration -- Technology application, Central nervous system depressants -- Technology application, Diseases -- Relapse, Dexamethasone -- Technology application, Multiple myeloma -- Drug therapy, Drug approval -- Technology application, Technology application, Business, News, opinion and commentary, European Union -- Technology application, Darzalex (Medication)
Abstract

SAN DIEGO, Nov. 12, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the Janssen Pharmaceutical Companies submitted regulatory applications to the U.S. Food and Drug Administration (FDA) [...]

Published
2020

43. AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ(TM) (upadacitinib) in Atopic Dermatitis

Subjects
United States. Food and Drug Administration -- Technology application, Allergan PLC -- Technology application, AbbVie Inc. -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Atopic dermatitis -- Technology application, Adalimumab -- Technology application, Drug approval -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Business, News, opinion and commentary, Rinvoq (Medication)
Abstract

- In three pivotal Phase 3 studies, RINVOQ met co-primary and all secondary endpoints in adult and adolescent patients with moderate to severe atopic dermatitis[1-3] - Also known as eczema, [...]

Published
2020

44. Micron Biomedical Progresses with Clinical Evaluation of Its Technology for Measles-Rubella Vaccination

Subjects
Medical research -- Technology application, Medicine, Experimental -- Technology application, Vaccination -- Technology application, Measles-mumps-rubella vaccine -- Technology application, Influenza vaccines -- Technology application, Influenza -- Drug therapy, Clinical trials -- Technology application, Drug approval -- Technology application, Rubella -- Drug therapy, Technology application, Business, News, opinion and commentary
Abstract

Under $6.745 Million Grant from the Bill & Melinda Gates Foundation ATLANTA, Sept. 1, 2020 /PRNewswire/ -- Micron Biomedical, Inc. (Micron) recently received a second tranche of funding ($2.6M) to [...]

Published
2020

45. The EU Commission grants conditional approval for IdefirixTM (imlifidase) in highly sensitized kidney transplant patients in the European Union

Subjects
Kidneys -- Transplantation, Biological products industry -- Technology application, Drug approval -- Technology application, Enzymes -- Technology application, Immunoglobulin G -- Technology application, Technology application, Business, News, opinion and commentary, European Union. European Commission -- Technology application
Abstract

The conditional approval by the European Commission serves as a landmark milestone for Hansa Biopharma, as IdefirixTM (imlifidase) will be the Company's first approved drug and will transform Hansa Biopharma [...]

Published
2020

46. TWi Biotechnology Receives Canada Health Approval for AC-1101 Phase 1 CTA

Subjects
United States. Food and Drug Administration -- Technology application, Biotechnology -- Technology application, Drug approval -- Technology application, Clinical trials -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

TAIPEI, Taiwan, May 7, 2020 /PRNewswire/ --TWi Biotechnology (TWiB) announced that they have received Clinical Trial Application (CTA) approval from the Health Canada to conduct a Phase 1 clinical trial [...]

Published
2020

47. Imprimis files Form 8-K with SEC for Surface Pharmaceuticals subsidiary

Subjects
Drug approval -- Technology application, Eye diseases -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

Imprimis Pharmaceuticals announced it has filed a Form 8-K with the SEC which contains a corporate presentation for its subsidiary, Surface Pharmaceuticals. Surface Pharmaceuticals intends to advance state of the [...]

Published
2017

48. Thermo Fisher notes CTS Dynabeads' use in Novartis' CAR-T cell therapy

Subjects
Genetic engineering -- Technology application, Genetically modified organisms -- Technology application, Drug approval -- Technology application, T cells -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

After the FDA approved Novartis' (NVS) chimeric antigen receptor T cell therapy, Kymriah, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia [...]

Published
2017

49. AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency

Subjects
United States. Food and Drug Administration -- Technology application, Psoriasis -- Drug therapy, Antiarthritic agents -- Technology application, Drug approval -- Technology application, Technology application, Business
Abstract

M2 EQUITYBITES-April 8, 2021-AbbVie submits SKYRIZI approval applications to US FDA and European Medicines Agency (C)2021 M2 COMMUNICATIONS http://www.m2.com United States-based AbbVie (NYSE: ABBV) announced on Wednesday that it has [...]

Published
2021

50. Anti-Fog Coated Films help prevent condensation

Subjects
Drug approval -- Technology application, Vegetables -- Technology application, Technology application, Business, Computers and office automation industries, High technology industry
Abstract

Suitable for packaging of vegetables and fruits, anti-fog OPP film with controlled perforation helps keep produce fresh. Coated films do not alter coefficient of friction (COF), while providing improved transparency. [...]

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results